임신 중 선천성 거대세포바이러스 감염: 순차적 뇌변화를 보이는 증례 보고와 최신 진단, 치료 및 예방 = Congenital Cytomegalovirus Infection in Pregnancy: A Case Report with Sequential Fetal Brain Changes and the Latest Information on Diagnosis, Treatment and Prevention

다국어 초록 (Multilingual Abstract)

Congenital cytomegalovirus (CMV) infection is the most common nongenetic cause of sensorineural hearing loss and a major cause of visual, intellectual, and neurodevelopmental impairment worldwide. The seroprevalence of CMV among women of childbearing age in developing countries reaches almost 100%, and the incidence of CMV infection in neonates is 1%-2%. Approximately 87% of the infected neonates are asymptomatic at birth and 13% of them have permanent sequelae. The burden of congenital malformations due to congenital CMV infection is higher than that due to Down syndrome, fetal alcohol syndrome, and spina bifida. Nevertheless, there is little knowledge regarding congenital CMV pathogenesis, diagnosis, treatment, and prevention. In this study, we report a case that showed sequential changes of fetal brain following CMV infection in pregnancy. Additionally, we reviewed the latest information on the diagnosis, treatment, and prevention of congenital CMV infection.

참고문헌 (Reference)

1 American Academy of Pediatrics, "Year 2007 position statement : principles and guidelines for early hearing detection and intervention programs" 120 : 898-921, 2007

2 Manicklal S, "The"silent"global burden of congenital cytomegalovirus" 26 : 86-102, 2013

3 Dreher AM, "Spectrum of disease and outcome in children with symptomatic congenital cytomegalovirus infection" 164 : 855-859, 2014

4 Boppana SB, "Saliva polymerase-chain-reaction assay for cytomegalovirus screening in newborns" 364 : 2111-2118, 2011

5 Cannon MJ, "Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection" 20 : 202-213, 2010

6 Kenneson A, "Review and meta-analysis of the epidemiology of congenital cytomegalovirus(CMV)infection" 17 : 253-276, 2007

7 Fabbri E, "Prognostic markers of symptomatic congenital human cytomegalovirus infection in fetal blood" 118 : 448-456, 2011

8 Revello MG, "Prevention of primary cytomegalovirus infection in pregnancy" 2 : 1205-1210, 2015

9 Adler SP, "Prevention of child-tomother transmission of cytomegalovirus among pregnant women" 145 : 485-491, 2004

10 Barber V, "Prevention of acquisition of cytomegalovirus infection in pregnancy through hygiene-based behavioral interventions : a systematic review and gap analysis" 39 : 949-954, 2020

11 Nigro G, "Passive immunization during pregnancy for congenital cytomegalovirus infection" 353 : 1350-1362, 2005

12 Coats DK, "Ophthalmologic findings in children with congenital cytomegalovirus infection" 4 : 110-116, 2000

13 Yinon Y, "No. 240-Cytomegalovirus infection in pregnancy" 40 : e134-41, 2018

14 Dollard SC, "New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection" 17 : 355-363, 2007

15 Pass RF, "Mother-to-child transmission of cytomegalovirus and prevention of congenital infection" 3 (3): S2-S6, 2014

16 Dahle AJ, "Longitudinal investigation of hearing disorders in children with congenital cytomegalovirus" 11 : 283-290, 2000

17 Boppana SB, "Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity" 344 : 1366-1371, 2001

18 Enders G, "Intrauterine transmission and clinical outcome of 248 pregnancies with primary cytomegalovirus infection in relation to gestational age" 52 : 244-246, 2011

19 Xu H, "Intrauterine cytomegalovirus infection: a possible risk for cerebral palsy and related to its clinical features, neuroimaging findings: a retrospective study" 20 : 555-, 2020

20 Bodéus M, "Increased risk of cytomegalovirus transmission in utero during late gestation" 93 (93): 658-660, 1999

21 Leruez-Ville M, "In utero treatment of congenital cytomegalovirus infection with valacyclovir in a multicenter, open-label, phase II study" 215 : 462.e1-462.e10, 2016

22 Bardanzellu F, "Human breast milk-acquired cytomegalovirus infection: certainties, doubts and perspectives" 15 : 30-41, 2019

23 Foulon I, "Hearing loss in children with congenital cytomegalovirus infection in relation to the maternal trimester in which the maternal primary infection occurred" 122 : 1123-1127, 2008

24 Leruez-Ville M, "Fetal cytomegalovirus infection" 38 : 97-107, 2017

25 Leruez-Ville M, "Feasibility of predicting the outcome of fetal infection with cytomegalovirus at the time of prenatal diagnosis" 215 : 342.e1-342.e9, 2016

26 Retzler J, "Economic cost of congenital CMV in the UK" 104 : 559-563, 2019

27 Boppana SB, "Dried blood spot real-time polymerase chain reaction assays to screen newborns for congenital cytomegalovirus infection" 303 : 1375-1382, 2010

28 Jiyeon Kim, "Diagnostic Clues for Congenital Cytomegalovirus Infection: Association with Newborn Hearing Screening Tests" 대한신생아학회 26 (26): 96-101, 2019

29 Society for Maternal-Fetal Medicine(SMFM), "Diagnosis and antenatal management of congenital cytomegalovirus infection" 214 : B5-11, 2016

30 Schaefer MR, "Development and assessment of a prenatal cytomegalovirus(cmv)educational survey : implementation and impact in a metropolitan university-based clinic" 12 : 1205-1214, 2020

31 Bate SL, "Cytomegalovirus seroprevalence in the United States: the national health and nutrition examination surveys, 1988-2004" 50 : 1439-1447, 2010

32 Carlson A, "Cytomegalovirus infection in pregnancy: should all women be screened?" 3 : 172-179, 2010

33 Navti OB, "Cytomegalovirus infection in pregnancy-an update" 258 : 216-222, 2021

34 Yinon Y, "Cytomegalovirus infection in pregnancy" 32 : 348-354, 2010

35 Grosse SD, "Congenital cytomegalovirus(CMV)infection as a cause of permanent bilateral hearing loss : a quantitative assessment" 41 : 57-62, 2008

36 Colomba C, "Congenital cytomegalovirus related intestinal malrotation : a case report" 42 : 105-, 2016

37 Pass RF, "Congenital cytomegalovirus infection following first trimester maternal infection : symptoms at birth and outcome" 35 : 216-220, 2006

38 Chiopris G, "Congenital cytomegalovirus infection : update on diagnosis and treatment" 8 : 1516-, 2020

39 Boppana SB, "Congenital cytomegalovirus infection : clinical outcome" 57 (57): S178-S181, 2013

40 De la Calle M, "Combined treatment with immunoglobulin and valaciclovir in pregnant women with cytomegalovirus infection and high risk of symptomatic fetal disease" 15 : 1-5, 2020

41 Leruez-Ville M, "Accuracy of prenatal ultrasound screening to identify fetuses infected by cytomegalovirus which will develop severe long-term sequelae" 57 : 97-104, 2021

42 Revello MG, "A randomized trial of hyperimmune globulin to prevent congenital cytomegalovirus" 370 : 1316-1326, 2014